Skip to content
Recall Observatory FDA recall evidence

Drug product

Zonisamide Capsules, USP, 100 mg, packaged in: a) 100-count bottle (NDC 68462-130-01); b) 500-count bottle (NDC 68462-130-05), Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

D-0793-2022

April 25, 2022

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 90029
Status
Completed
Classification
Class II
Quantity
a) 7,044 bottles; b) 1,014 bottles
Official record key
drug-enforcement:D-0793-2022

Official wording

Reason: cGMP deviations

Code information: a) Lot #: 29200053, Exp 4/30/2023; b) Lot #: 29200054, Exp 4/30/2023

Distribution pattern: USA nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations